Acco Group Holdings Ltd ACCL

Industrials SIC 8742 - Services-Management Consulting Services NAICS Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Management Consulting Services › Administrative Management and General Management Consulting Services derived Nasdaq

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.08

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022
Revenue $4.9M$4.4M$3.7M—
Cost of revenue $2.5M$2.0M$1.8M—
Gross profit $2.1M$2.1M$1.7M—
SG&A $654.7K$522.0K$708.3K—
Total operating expenses $1.1M$1.1M$1.3M—
Operating income $1.1M$1.1M$482.2K—
Pre-tax income $1.2M$1.1M$692.2K—
Income tax $130.5K$127.2K$50.3K—
Net income $1.0M$992.8K$641.9K—
EPS, basic 0.080.080.05—
EPS, diluted 0.080.080.05—
Shares, diluted (wtd. avg.) 12.5M12.5M12.5M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022
Cash and equivalents $2.5M$1.1M$1.8M$2.2M
Receivables $293.6K$245.5K——
Total current assets $2.9M$2.6M——
Property, plant and equipment $27.6K$14.7K——
Total assets $3.9M$2.7M——
Accounts payable $38.0K$19.3K——
Total current liabilities $1.6M$1.5M——
Total liabilities $1.7M$1.5M——
Retained earnings $2.1M$1.1M——
Total equity $2.2M$1.1M$2.1M$2.1M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022
Operating cash flow $1.5M$1.1M$742.0K—
Depreciation and amortisation $10.3K$9.3K——
Capital expenditure $23.2K$1.3K$7.7K—
Investing cash flow -$23.2K-$1.3K-$7.7K—
Financing cash flow -$1.1M-$882.8K-$1.1M—
Dividends paid ——$51.9K—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-25-111270.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2M 4M 6M Revenue, FY2023: 3.7M Gross profit, FY2023: 1.7M Net income, FY2023: 641.9K Revenue, FY2024: 4.4M Gross profit, FY2024: 2.1M Net income, FY2024: 992.8K Revenue, FY2025: 4.9M Gross profit, FY2025: 2.1M Net income, FY2025: 1M FY2022 FY2023 FY2024 FY2025
Fiscal year FY2022FY2023FY2024FY2025
Revenue — $3.7M $4.4M $4.9M
Gross profit — $1.7M $2.1M $2.1M
Net income — $641.9K $992.8K $1.0M

Others in SIC 8742

TickerCompanyMarket capP/ERevenue growth
BAH Booz Allen Hamilton Holding Corp $9.42B 11.4x -6.4%
G Genpact LTD $6.86B 13.0x 6.6%
FCN FTI CONSULTING, INC $4.34B 19.1x 2.4%
EXPO EXPONENT INC $3.68B 37.4x 4.2%
HURN Huron Consulting Group Inc. $3.17B 33.5x 11.9%
ASTH Astrana Health, Inc. $2.09B 81.4x 56.4%
ICFI ICF International, Inc. $1.69B 19.1x -7.3%
BWMN Bowman Consulting Group Ltd. $742.5M 58.7x 14.9%